• D-Mannitol B2090: Product Overview

  2026-10-07

  D-Mannitol (SKU B2090) is a supplier-listed biochemical reagent with the formula C6H14O6 and a molecular weight of 182.17. Its stated conceptual scope includes osmotic regulation research, renal function studies, and diuretic mechanism investigation. No matched paper evidence was provided for this specific product.

• BHPF–GPER Binding and Neuroblastoma Apoptosis

  2026-10-07

  A 2024 Environmental Science & Technology study combined molecular dynamics, receptor perturbation, and cell-based assays to investigate how fluorene-9-bisphenol (BHPF) interacts with GPER. The findings identify a potential inhibitory recognition mechanism involving two receptor residues and connect disrupted GPER signaling with altered calcium responses and neuroblastoma-cell toxicity.

• Heparin Sodium in Coagulation and Vesicle Research

  2026-10-06

  A source-grounded overview of heparin sodium as a glycosaminoglycan anticoagulant, its established relevance to coagulation research, and the cautious hypothesis that heparan sulfate biology may connect anticoagulant and plant-vesicle studies.

• G-1: Interpreting GPR30 Signaling Evidence

  2026-10-06

  G-1 is a selective GPR30 agonist used to investigate rapid estrogen-receptor signaling across immune, cancer, and cardiovascular models. This evidence-focused analysis explains what the data show, where interpretation is strongest, and which limitations matter for translational research.

• Danazol as an Endocrine Perturbation Probe

  2026-10-05

  Danazol is more than a weak androgenic steroid: it is a mechanistically complex probe for steroidogenesis, LH regulation, and HPG-axis biology. This evidence-focused analysis interprets a 2025 rat study while clarifying model boundaries, translational relevance, and the role of Danocrine in endocrine research.

• BMS 309403 and the FABP4 Axis in Atherosclerosis

  2026-10-05

  A source-grounded perspective on how BMS 309403 can help translational researchers interrogate the SERCA2–calcineurin–FoxO1–FABP4 pathway, with emphasis on mechanistic evidence, study boundaries, and the path from target validation to clinically relevant research.

• D-Mannitol B2090 Product Overview

  2026-10-04

  D-Mannitol B2090 is a supplier-described biochemical reagent for conceptual osmotic regulation research, with no matched paper evidence supplied for this product.

• AST 487 and the KDM4A Translational Thesis

  2026-10-03

  KDM4A has emerged as a compelling preclinical dependency in malignant pleural mesothelioma, but the path from mechanistic signal to translational confidence requires careful separation of published evidence, research hypotheses, and product provenance. This thought-leadership analysis places AST 487 within that framework without treating a research reagent as clinical validation.

• L-Glutathione Reduced in Redox Research

  2026-10-02

  L-Glutathione Reduced is reduced glutathione, an endogenous thiol-containing tripeptide used to study redox control, detoxification, and GST affinity workflows. Its defined composition and handling profile support reproducible assays, while the cited GOT1 study shows why redox measurements require mechanistic controls in pancreatic cancer research.

• Tin Mesoporphyrin IX: HO Inhibition Workflows

  2026-10-01

  Tin Mesoporphyrin IX (chloride) helps researchers test whether heme oxygenase activity, rather than HO-1 expression alone, drives oxidative, metabolic, or viral phenotypes. This workflow-oriented guide covers enzyme assays, HBV-relevant readouts, dosing controls, and troubleshooting for more causal experiments.

• URB597 and the Next Era of Endocannabinoid Translation

  2026-10-01

  URB597, also known as KDS-4103, offers a selective way to interrogate FAAH-dependent anandamide biology. This thought-leadership analysis connects mechanistic evidence from inflammatory pain research with practical guidance for neuroplasticity, neuroinflammation, and translational endocannabinoid studies.

• ATP Solution for p21 mRNA Workflows

  2026-09-30

  A practical guide to using ATP Solution (100 mM) across IVT mRNA production, kinase testing, ligation, and phosphorylation assays that support p21 mRNA–LNP research. It separates product-backed specifications from optimization starting points and shows how disciplined ATP handling improves upstream reproducibility without overstating its role in bladder cancer therapy.

• D-Mannitol B2090: Practical Research Workflow

  2026-09-30

  D-Mannitol B2090 provides a defined, water-soluble reagent for controlled osmotic regulation research, renal function studies, and diuretic mechanism investigation. It is intended for laboratory workflows rather than clinical treatment, and freshly prepared solutions should be used promptly because long-term solution storage is not recommended.

• Deep Learning for iPSC-CM Cardiotoxicity Screening

  2026-09-29

  The eLife study developed a deep-learning and high-content imaging workflow for detecting cardiotoxic phenotypes in human iPSC-derived cardiomyocytes. Its target-agnostic scoring strategy identified liabilities across ion-channel, kinase, DNA-intercalating, and other compound classes, supporting earlier safety decisions in drug discovery.

• SLC25A1 Links Mitochondria to PD-L1 and IFN-I

  2026-09-29

  This bioRxiv preprint identifies SLC25A1 as a tumor-intrinsic regulator connecting mitochondrial signaling, type I interferon activity, and PD-L1 protein stability. Its findings suggest that SLC25A1 may simultaneously promote immune evasion and create a context-dependent vulnerability to PD-L1 blockade, although validation in peer-reviewed and clinically representative systems remains necessary.

8027 records 1/536 page Next 12345 下5页 Last page